Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs PROCTER & GAMBLE HEALTH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA PROCTER & GAMBLE HEALTH ALEMBIC PHARMA/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x 32.2 34.5 93.5% View Chart
P/BV x 4.4 10.5 42.0% View Chart
Dividend Yield % 0.8 2.0 40.3%  

Financials

 ALEMBIC PHARMA   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-23
PROCTER & GAMBLE HEALTH
Jun-23
ALEMBIC PHARMA/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs7925,366 14.8%   
Low Rs4633,883 11.9%   
Sales per share (Unadj.) Rs287.6740.7 38.8%  
Earnings per share (Unadj.) Rs17.4138.2 12.6%  
Cash flow per share (Unadj.) Rs31.4155.2 20.2%  
Dividends per share (Unadj.) Rs8.0095.00 8.4%  
Avg Dividend yield %1.32.1 62.0%  
Book value per share (Unadj.) Rs222.3447.6 49.7%  
Shares outstanding (eoy) m196.5616.60 1,184.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.26.2 35.0%   
Avg P/E ratio x36.133.5 107.9%  
P/CF ratio (eoy) x20.029.8 67.1%  
Price / Book Value ratio x2.810.3 27.3%  
Dividend payout %46.068.7 66.9%   
Avg Mkt Cap Rs m123,40276,761 160.8%   
No. of employees `000NANA-   
Total wages/salary Rs m11,6912,062 567.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m56,52612,296 459.7%  
Other income Rs m30184 16.5%   
Total revenues Rs m56,55712,480 453.2%   
Gross profit Rs m6,7723,247 208.6%  
Depreciation Rs m2,754281 980.2%   
Interest Rs m5028 6,515.6%   
Profit before tax Rs m3,5463,142 112.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m126847 14.9%   
Profit after tax Rs m3,4202,295 149.0%  
Gross profit margin %12.026.4 45.4%  
Effective tax rate %3.627.0 13.2%   
Net profit margin %6.118.7 32.4%  
BALANCE SHEET DATA
Current assets Rs m29,13911,713 248.8%   
Current liabilities Rs m16,4086,791 241.6%   
Net working cap to sales %22.540.0 56.3%  
Current ratio x1.81.7 103.0%  
Inventory Days Days10263 3.7%  
Debtors Days Days7343 2.0%  
Net fixed assets Rs m31,49810,617 296.7%   
Share capital Rs m393166 236.8%   
"Free" reserves Rs m43,3127,265 596.2%   
Net worth Rs m43,7057,431 588.2%   
Long term debt Rs m00-   
Total assets Rs m60,63722,330 271.6%  
Interest coverage x8.1409.1 2.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.6 169.3%   
Return on assets %6.510.3 62.7%  
Return on equity %7.830.9 25.3%  
Return on capital %9.342.4 21.8%  
Exports to sales %46.40-   
Imports to sales %12.113.1 92.8%   
Exports (fob) Rs m26,210NA-   
Imports (cif) Rs m6,8461,605 426.4%   
Fx inflow Rs m26,2101,465 1,788.8%   
Fx outflow Rs m6,8461,605 426.4%   
Net fx Rs m19,364-140 -13,812.0%   
CASH FLOW
From Operations Rs m7,2402,360 306.8%  
From Investments Rs m-4,476-215 2,081.8%  
From Financial Activity Rs m-2,620-985 266.0%  
Net Cashflow Rs m1441,160 12.4%  

Share Holding

Indian Promoters % 69.1 0.0 -  
Foreign collaborators % 0.5 51.8 1.0%  
Indian inst/Mut Fund % 19.0 20.3 93.9%  
FIIs % 4.5 7.6 59.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 48.2 63.1%  
Shareholders   85,212 56,730 150.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ALEMBIC PHARMA vs Procter & Gamble Health

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALEMBIC PHARMA vs Procter & Gamble Health Share Price Performance

Period ALEMBIC PHARMA Procter & Gamble Health S&P BSE HEALTHCARE
1-Day -0.15% -0.55% 1.18%
1-Month -4.30% -7.47% -0.75%
1-Year 105.43% -3.02% 61.82%
3-Year CAGR 0.89% -9.12% 18.16%
5-Year CAGR 13.56% 5.75% 19.79%

* Compound Annual Growth Rate

Here are more details on the ALEMBIC PHARMA share price and the Procter & Gamble Health share price.

Moving on to shareholding structures...

The promoters of ALEMBIC PHARMA hold a 69.6% stake in the company. In case of Procter & Gamble Health the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALEMBIC PHARMA and the shareholding pattern of Procter & Gamble Health.

Finally, a word on dividends...

In the most recent financial year, ALEMBIC PHARMA paid a dividend of Rs 8.0 per share. This amounted to a Dividend Payout ratio of 46.0%.

Procter & Gamble Health paid Rs 95.0, and its dividend payout ratio stood at 68.7%.

You may visit here to review the dividend history of ALEMBIC PHARMA, and the dividend history of Procter & Gamble Health.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.